| AMPAR | alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor |
| AChE | acetylcholinesterase |
| AO | adverse outcome |
| AOP | adverse outcome pathway |
| AUC | area under the ROC curve |
| AUR-TPO | Amplex UltraRed-thyroperoxidase |
| BA | balanced accuracy |
| BRF | balanced random forest |
| CAR | constitutive androstane receptor |
| CYP2E1 | cytochrome P450 2E1 |
| DNT | developmental neurotoxicity |
| FN | false negative |
| FP | false positive |
| GABAR | GABA receptor |
| IATA | integrated approaches to testing and assessment |
| KA | kainite receptor |
| KE | key event |
| k-NN | k-nearest neighbors |
| MCC | Matthew’s correlation coefficient |
| MIE | molecular initiating event |
| NADHOX | NADH-quinone oxidoreductase |
| NIS | Na+/I− symporter |
| ND | neurodegenerative disease |
| NNET | neural networks |
| NMDAR | N-methyl-D-aspartate receptor |
| OATP1C1 | solute carrier organic anion transporter family member 1C14 |
| PCB | polychlorinated biphenyls |
| PXR | pregnane X receptor |
| QSAR | quantitative structure-activity relationship |
| RF | random forest |
| ROS | reactive oxygen species |
| RyR | ryanodine-sensitive Ca2+ channel |
| SEN | sensitivity |
| SPE | specificity |
| THRα | thyroid hormone receptor α |
| THRβ | thyroid hormone receptor β |
| TN | true negative |
| TP | true positive |
| TPO | thyroperoxidase |
| TTR | transtyretrin serum binding protein |
| VGSC | voltage-gated sodium channel |